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Functional changes of monocytes due to dialysis membranes. The
functional effects directly induced by dialysis membranes on peripheral
monocytes were analyzed in a plasma-free model of simulated dialy-
sis using Cuprophan, cuprammonium rayon, polyacrylonitrile, poly-
methylmetacrilate and polysulphone membranes. A severe reduction of
monocyte phagocytosis of lgG-coated erythrocytes was found by using
Cuprophan and cuproammonium rayon. The cytofluorimetric analysis
of several cell surface receptors, involved in the immune phagocytosis
and recognizable by five quoted monoclonal antibodies, did not reveal
any significant change. The defective phagocytosis of the lgG-coated
erythrocytes by monocytes, due to the exposure to cellulose-derived
membranes, was paralleled by an impaired interiorization of heat-
aggregated human immunoglobulins, as analyzed by electron micros-
copy. The cell membrane binding of aggregated immunoglobulins was
found to be unaffected. The defect was associated to a remarkably
depressed generation of reactive oxygen species after Zymosan stimu-
lation. Therefore, the defective immune phagocytosis induced by
exposure of monocytes to cellulosic membranes was not due to a
receptor rearrangement or n impaired binding of ingestible particles,
but to a reduced internalization capacity probably related to an energy
source exhaustion (as shown by the lack of response to stimuli able to
induce oxidizing species production). These features are similar to
those described in monocytes from acute systemic lupus erythematosus
patients.
The interaction of the blood with cellophane-derived dialysis
membranes induces modifications in several blood components
leading to complement activation [1—3], leukocytopenia f 3, 4]
and thrombocitopenia [5]. These modifications remain, in most
instances, asymptomatic, but may result in hemodynamic dis-
turbances [6] or inflammatory reactions such as acute phase
changes [7—9]. It is accepted that the majority of the nonphys-
iologic events deriving from blood/membrane interaction result
from the activation of the complement system triggered by
dialysis membranes. These observations provided the stimulus
for the examination of less commonly used dialysis membranes
that are free of this troublesome property. Several complement-
independent pertubations in cell functions have, however, been
demonstrated in dialysis patients. They include depressed cell-
mediated immunity [10, 11], impaired antibody response [12,
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13], reduced neutrophyl chemiotaxis [14, 15] and phagocytic
activity [16].
Apart from Nguyen and coworkers' careful study [17] in
which in vitro experiments on isolated leukocytes paralleled in
vivo observations on the oxidative metabolism of polymorpho-
nuclear cells, very few data have been reported on direct
influences (non-mediated by plasmatic factors) of dialysis ma-
terial on single cell functions. This is due in part to the fact that
the majority of the studies were done on whole blood, which is
a complex biological system with innumerable variables.
In the present study, the effects of dialysis membranes on
single cell functions were analyzed by working in a serum free
system of simulated dialysis with highly purified monocytes.
This approach of study avoided serum component interferences
and cell to cell interactions.
As bacterial infections are a major cause of morbidity in
uremic patients [131, the influence of contact of different dialy-
sis membranes on receptor mediated phagocytosis of IgG-
coated red blood cells (RBC) by monocytes was examined. The
results were related to the effects of dialysis materials on
oxidative metabolism, as detected by both the superoxide anion
test and the chemiluminescence assay, together with the capac-
ity of cells to ingest heat aggregated IgG, as evaluated by
electron microscopy. Moreover, the receptor assessment of
phagocyte cells was done by using monoclonal antibodies
recognizing some cell surface glycoproteins involved in the
mechanisms of immune phagocytosis.
Our results demonstrate that dialysis membranes affect the
phagocyte function to different extents. This influence is direct
and produces, in the experimental conditions employing cellu-
lose-derived membranes, a combination of impaired phagocyte
function with normal Fc receptor expression and exhaustion of




Blood collection. For each experiment 250 ml of Rh-positive
fresh venous blood were collected in phosphate citrate dextrose
solution from healthy donors of the Associazione Italiana
Volontari Sangue (AVIS). Blood was immediately processed.
Leukocyfe isolation. Monocytes were isolated as previously
described [211. Briefly, blood diluted 1:3 with 0.15 M NaCl was
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layered on 1.085 gIml Percoll (Pharmacia P-L Biochemicals,
Uppsala, Sweden) solution and centrifuged at 800 x g for 20
minutes at 22°C. The mononuclear cell interface band was
resuspended in 0.15 M NaC1, layered on 1.064 gIml Percoll
solution and centrifuged at 800 x g for 60 minutes at 4°C to
obtain a pellet which was found to contain mainly monocytes.
The cells were collected and washed in RPM! 1640 medium
(Difco Laboratories, Detroit, Michigan, USA) supplemented
with 3% bovine serum albumin (BSA) by centrifugation at 400
X g for 15 minutes at 4°C. This procedure resulted in cell
suspensions containing 8 to 15% OKT3-positive cells (Ortho,
Raritan, New Jersey, USA), 5 to 11% cells reacting with
anti-Leu 12 (Becton Dickinson Monoclonal Center, California,
USA) and 78 to 87% OKMI-positive cells, assumed to be
monocytes, with a final yield of 48 9.5%. Suspensions
included 0 to 3% neutrophils as judged on smears stained by
May-Grunwald-Giemsa.
In some experiments polymorphonuclear phagocytes were
also tested. Neutrophils were separated by Voss-Jepsen's one-
step method [221 using two different gradients of Percoll. This
precedure resulted in a neutrophil suspension with more than
95% purity. Monocytes and neutrophils were resuspended in
appropriate volumes of RPM! 16403% BSA before testing them
in recirculation experiments.
Simulated dialysis circuit
Beilco-Unimat machines (BL 723) were used to run dialyzate
at a flow rate of 500 mI/mm in a single pass fashion. Dialyzate
composition included the following salt concentrations: Na
140 mEq/liter, K 1.5 mEq/liter, Mg 1.5 mEq/liter, Ca + 3.5
mEq/liter, HC03 31 mEq/liter, acetate 5 mEq/liter, chloride
11.5 mEq/liter. Dialyzate temperature was maintained at 38°C.
The simulated dialysis system included dialyzate tubing sets BL
363B and BL 5022 (Bellco), and blood tubes (appropriately
shortened to reduce blood priming) BL 304-037 12 and BL
352-004428 (BeIlco). The following dialyzers were used: capil-
lary flow dialyzer model ST 12 (Travenol) surface area 0.8 sm
and 1.1 sm parallel plate dialyzer BL 500 (Bellco), both of
Cuphrophane (Cu), cuprammonium rayon (CuR) 1.2 sm hollow-
fiber model TAF 12 (Terumo), polyacrylonitrile (PAN) AN 69
model H 12.07, 0.7 sm (Hospal), polymethylmetacrilate
(PMME) hollow-fiber Filtryzer B 2-150, 1.2 sm (Toray Indus-
tries mc), and Polysulphone (PS) hollow-fiber Spiraflo HFT 10
(Sorin Biomedica) 1 Sm.
A permanent bypass circuit was assembled in which, after
rinsing with 2 to 4 liters 0.15 M NaCI solution, suspensions of
1.8 to 2.5 x l0 monocytes or neutrophils/mI in RPM!, 3%
BSA, were recirculated for 60 minutes. In order to reintegrate
the fluid removal, particularly remarkable with highly water
permeable membranes, a balanced salt solution was connected
to the bypass circuit.
During the procedure, samples were taken at different times,
cell suspensions were centrifuged and phagocyte cells assessed
for the following assays.
Cell viability test
Cell viability was evaluated by the Ethidium-Bromide immu-
nofluorescence exclusion test [211 and the detection of lactic
dehydrogenase (LDH; UV-cinetic test, cod 19712, Merck,
Darmstatt, FRG) released in the supernatants by aliquots of cell
suspensions collected after diverse periods of exposure to the
different dialysis membranes. The values were referred to those
of non-recirculated control-cell preparations.
Fc receptor-in ediated phagocytosis of monocytes
Identical aliquots of 0.5 x 106 monocytes, collected at
different times of exposure to the various dialysis membranes,
were tested for their ability to ingest autologous erythrocytes
coated with lgG anti-Rh (D) (Centre de Transfusion Sanguine,
Lyon, France) co-incubated in duplicate in a humid atmosphere
at 37°C for 45 minutes. At the end of the incubation a solution
of acridine orange was added vol to vol to the cell suspension
and one drop of the mixture was placed on a glass slide. One
hundred consecutive cells and the total number of sensitized
RBC ingested were counted [231.
To express results, the phagocytosis indexes (number of
ingested RBC/lOO monocytes) were related to the values of
non-recirculated control cell preparations from the same donor.
Surface receptor assessment of phagocyte cells
The following monoclonal antibodies (MoAbs) were em-
ployed: AB 8.28 (Technogenetics, Italy) directed to Fc receptor
(FcR) of polymorphonuclear phagocytes and Large Granular
Lymphocytes [24], CBO4 directed to the C3b receptor (CR1) of
circulating phagocytes [25], OKMI (Orto-mune Ortho Diagnos-
tic System) directed to the C3bi receptor (CR3), AA 3.84 to
class II HLA antigens [26], and CB 12 which recognizes a
marker of monocyte differentiation strongly expressed on mono-
cytes and their precursors in the bone marrow [271. The
quantitative expression of the epitopes recognized by these
MoAb was evaluated by using a direct fluorescence test for the
previously fluorescein-conjugated AA3.84 MoAb and indirect
fluorescence assay (using a fluorescein-labelled affinity-purified
goat antibody to mouse gammaglobulins) for the other MoAbs.
A hundred microliters of suspension of monocytes or neutro-
phils [5 x 106 cells/mI in phosphate buffered saline (PBS)} were
incubated in an ice bath for 30 minutes with 5 s1 of AA3.84 and
OMKI MoAbs or 3 d of AB 8.28, CBI2 and CBO4 and then
washed with PBS. With the exception of AA 3.84-treated cell
suspensions, the phagocytes were then incubated with 5 d of
fluorescein-labeled antibodies to mouse gamma globulins in an
ice bath for an additional 30 minutes, washed with PBS and
resuspended at the appropriate concentrations. The cells were
processed through a Spectrum III flow cytofluorometer (Ortho
Diagnostic System). The green fluorescence signals passed
through the gate window of monocytes or neutrophils were
measured and displayed as a histogram. A monocyte window
was previously selected by passing monocytes isolated by
double gradients of Percoll as described above, and subse-
quently allowed to adhere to solid substrates of Petri disks for
45 minutes at 37°C and recovered by vigorous pipetting in
ice-cold PBS, 10 msi ethylenediamine-tetra-acetate, pH 7.2. By
analyzing the reactivity to various MoAbs, including OKT3 and
Leul2, these cell suspensions were found to be virtually free of
mononuclear cells, other than monocytes.
Electron microscopy examination
Aliquots of 200 jsl of cell suspensions containing 1.5 to 2 x
106 monocytes exposed to PS or Cu membranes, processed
without dialyzer or non-processed (as controls), were mixed
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with 100 pi of 20 mg/mI heat-aggregated human gamma globu-
lins (AHGG; Human Cohn Fraction II, Sigma Chemical Co, St.
Louis, Missouri, USA). These mixtures were then incubated
for 15 minutes at 37°C under 60 rpm shaking and for an
additional 45 minutes without shaking. Then cells were washed
twice at 1000 x g for five minutes at 4°C with cold PBS, fixed in
2.5% glutaraldehyde, post-fixed in osmium tetroxide and em-
bedded in epoxy resin-ultrathin sections and finally stained with
uranyl acetate-lead citrate.
In additional experiments cell suspensions, incubated with
AHGG for 15 minutes at 22°C under shaking to promote the
uptake limiting the internalization, were reincubated for an-
other 15 minutes at 22°C after addition of 50 pi gold-labelled
goat antibody to human IgG (E-Y Lab mc, San Mateo, Califor-
nia, USA). incubation was then continued for 45 minutes at
37°C and the cell suspensions were washed and processed as
described above.
Superoxide anion production test
Superoxide anion generation by monocytes was measured
according to Bellavite's method [281 with slight modifications
by using, as a stimulating agent, opsonized Zymosan.
Zymosan (Zymosan A, Sigma Chemical Co.) was suspended
in 0.15 M NaCI to 20 mg/mI final concentration and boiled for 10
minutes. After washing, it was resuspended at the concentra-
tion of 10 mg/mI in Krebs-Ringer phosphate buffer supple-
mented by 0.5 mmol/l CaCI2 and 5 mmol/liter glucose (KRP).
Opsonization was obtained by incubating Zymosan with a pool
of fresh human serum (20%) at 37°C for 30 minutes under
shaking. After washing, particles were resuspended in KRP
buffer at 10 mg/ml.
Two series of 10 ml plastic test tubes were prepared. Each
tube contained 0.4 ml KRP buffer and 1.5 mg of cytochrome C
(Sigma Chemical Co.).
To the first series of tubes, 0.5 mg of opsonized Zymosan was
also added. The tubes were preincubated in a water bath for five
minutes at 37°C. Then aliquots of 0.1 ml from the monocyte
suspension under study were added to each tube and the
reaction was allowed to proceed for 30 minutes under 60 rpm
shaking. The reaction was stopped by adding 2 ml of ice-cold
KRP buffer containing 1 mmol/Iiter N-ethylmaleimide and the
tubes were centrifuged. The absorbance values (550 to 468 nm)
of the supernatants of the second series of tubes were sub-
tracted from those of the corresponding first series of tubes to
exclude the superoxide anion-independent reduction of cyto-
crome C. The results were corrected for the dilution factor, and
divided by 0.0245, the extinction coefficient mol/liter of cyto-
crome C determined at 550 to 468 nm and finally expressed as
nmol of superoxide anion produced by 106 monocytes.
Chemilu,ninescence assay
For this test Zymosan was opsonized as follows: fifty milli-
gram of Zymosan were incubated for 30 minutes in 3 ml fresh
human serum and 1 ml Hanks balanced salt solution without
phenol red (HBSS). After washing, Zymosan was resuspended
in HBSS at a concentration of 12.5 mg/mI.
A luminol stock solution was prepared by dissolving 1.77 mg
of luminol (LKB-Wallac 1243-2 16) in 1 ml dimethylsulphoxide
(DMSO) to obtain a concentration of 10_2 M. Immediately
before use, it was further diluted to l06 M in HBSS.
The instrumentation equipment included a LKB-Wallac 1251
luminometer coupled to display unit, potentiometric recorder
(2210-032) and computer (Olivetti M 24) employing a specific
PHAGO-TEST program (LKB), for data integration.
The following reagents were subsequently pipetted into du-
plicate cuvettes: 600 l of 106 M luminol, 50 pA of opsonized
Zymosan (or HBSS in controls) and 50 pA of monocyte suspen-
sion (106 cells/mI) under study, Suspensions were gently mixed
and cuvettes were conveyed to the measurement position.
Duplicate samples were measured at one minute intervals as
mV light emission. Results were automatically plotted on a
graph having light intensity units on the ordinate and time units
on the abscissa.
Statistics
For statistical analysis, Student's t-test for paired observa-
tions and the Wilcoxon test were used.
Results
Cell viability
Both the Ethidium bromide exclusion test and the detection
of LDH excluded the possibility that the experimental condi-
tions, per se, induced gross cell suffering, thus decreasing the
significance of the functional tests (Fig. 1). The changes in
viability values obtained from processed cells did not reach a
significant level as compared to the control values.
Fc receptor-mediated phagocytosis by monocytes
The effects of exposure of monocytes to different dialysis
membranes on phagocytosis of IgG-coated RBC by monocytes
are summarized in Figure 2. Each point on the graphs repre-
sents the mean of four to six separate experiments of recircu-
lation in the plasma free model of simulated dialysis. The
phagocytosis indexes at each time were referred to those of the
non-recirculated control cell preparations. A strong decrease in
immune phagocytosis was already found at 10 minutes of
circulation by using Cu flat sheet and Cu hollow-fiber dialyzers:
56 8% (mean SEM)and 45 6% (P < 0.01 in both cases) of
the control values, respectively. The decrease became even
more significant at 30 minutes (24 5% and 20 4%, P < 0.02
and <0.01 as compared to the 10 mm values), reaching the
maximum level at 60 minutes (19 6% and 15 8%, P = 0.05
as compared to the 30 mm values). CuR membrane showed
similar negative influence on recirculated monocytes with a
decline to 60 5% of the basal values at 10 minutes (P < 0.01)
and 45 8% at 30 minutes (P < 0.05 as compared to the 10 mm
values). PAN-AN 69 membranes induced a slight decrease in
monocyte phagocytosis (75 8% at 10 mm, P <0.1) reaching
a significant level at 30 and 60 minutes of recirculation (60 7%
and 57 6%, respectively, with P < 0.02 by comparing both the
values to control data). The immune phagocytosis was virtually
unaffected by PMME (80 3%, 84 8% and 80 5%,
respectively at 10, 30 and 60 mm), PS (93 8%, 93 4% and
88 5%) or by recirculation into the tubing sets without
dialyzer (98 1%, 96 2% and 98 0.5%).
Quantitative expression of cell surf ace receptors
The percentage of positive cells in monocyte and neutrophil






Fig. 2. Fc mediated phagocytosis of IgG
coated erythrocytes by monocytes recirculated
60 in a plasma free model of simulated dialysis.Each point represents the mean of 4 to
6 experiments.
membranes, as compared to their own control cell preparations,
is shown in Figure 3. Apart from a slight increase in AA3.84-
positive cells at a 10 minute circulation in presence of PS
membrane, no obvious change was detected. Similar data (not
shown) were obtained by analyzing the relative expression of
antigens at each time interval as relative fluorescence intensity
(mean channel SD).
Electron microscopy examination
In non-recirculated monocyte suspensions or in suspensions
processed for 30 minutes in absence of dialysis membrane and
incubated with AHGG, the aggregated immunoglobulins ap-
peared as granular electron-dense material ingested by mono-
cytes and detectable in lysosomes (Fig. 4A). Similar features
have been observed after recirculation in presence of PS
membranes (Fig. 4B). The immunoglobulin nature of the elec-
tron dense material has been confirmed by the detection in
lysosomes of anti-IgG antibody-coated gold particles strictly
associated to AHGG (Fig. 4C). In the suspensions exposed to
Cu membrane, the electron dense material appeared to be
closely associated to the monocyte plasma membrane, but it
was never observed as ingested material (Fig. 4D).
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Fig. 1. Cell viability. A. Ethidium-Bromide
immunofluorescence exclusion test. B.
Detection of lactic dehydrogenase released in
the supernatants from suffering cells. In










Monocytes the IgG-coated erythrocytes. The synthetic membranes, partic-
0KM 1 Mo Ab ularly PS, did not substantially influence the chemilumines-
cence of monocytes, whereas the cellulose derived dialysis
induced a remarkable decrease in this activity, suggesting that
this membrane was able to produce an exhaustion of cell energy
sources. We tried to catch the phase of prior activation causing
the energy exhaustion by analyzing the luminol enhanced
chemiluminescence in resting monocytes tested without Zymo-
san stimulation immediately after the exposure to the dialysis
I I I membranes. However, the values obtained, although consistent
10 30 50 with those of Zymosan-stimulation chemiluminescence, were
Time, minutes so low (likely due to the delay required for centrifugation and
resuspension of cells to an appropriate concentration) that they
did not permit reasonable speculations.AS 8.28 MoAb





AA 3.84 Mo Ab
100 ioo Discussion
Previous studies have shown a lower cell-mediated immunity
in uremic state including a high tendency to develop mesen-t 50 50 chymal tumors [29], impaired kidney and skin graft rejection
[30] and decline in delayed hypersensitivity reaction [30, 311.
The reduction of Nitroblue tetrazolium in dark formazan and
__________________
I I I thephagocytosis of pyogenic strains by neutrophils were found
10 30 50 10 30 50 to be deeply depressed in hemodialysis patients [32]. An
Time, minutes Time, minutes impairment in the ability of monocytes from uremic patients to
CB 04 CB 12 phagocytize IgG-coated RBC was also reported [33].
Monocytes respond to phagocytosis or perturbation of the
100 100 plasma membrane with a burst of oxygen comsumption. The
production of oxygen radicals by activated monocytes and
macrophages plays an important role in the ability of these cellst 50 st so - to participate in cell mediated immunity [34]. Again, monocytes
from hemodialysis patients were found to produce, to a lesser
extent, superoxide anion in comparison to healthy people [35].
I I I I I ___________________ In another report, neutrophils from hemodialysis patients had
10 30 50 10 30 50 significantly less of an increase in chemiluminescence emission
Time. minutes Time. minutes after soluble agent stimulation as compared with controls and a
Fig. 3. Cell surface receptor assessment of neutrophils and ,nonocytes defect intrinsic to the neutrophils from hemodialysis patients
exposed to different dialysis membranes. In abscissa: re-circulation was suggested as the cause [36]. Nguyen and coworkers [17]time. In ordinate: percentage of positive cells as compared to non- . .
recirculated control cell suspensions, found a significant reduction of reactive oxygen species produc-
tion by neutrophils after Zymosan stimulation at 15 minutes
from the start of dialysis with cellulosic membranes, but not
with PAN. This effect was transient and was reversed at the end
Superoxide anion production test of hemodialysis, likely due to the input of neutrophils entering
The distribution of superoxide anion forming activity by the bloodstream from the marginal compartments. Similar
monocytes stimulated by opsonized Zymosan after exposure to results were reported by others [37].
different dialysis membranes is reported in Figure 5. After a 30 Several other authors investigating the effects of dialysis
minute exposure to Cu membrane, an initial fall in this activity membranes on various cell functions and plasma properties
was observed (P < 0.05). This fall was found to be slightly reported differences between cellulose-derived and synthetic
greater at 45 minutes, and became maximal at 60 minutes (P < membranes [16, 38, 391. However, many of the reported data
0.01 compared to control values and P < 0.05 compared to 30 were dealing with whole blood and are difficult to interpret due
mm data). to the adverse effects of the reciprocal interferences between
plasma components and cells or even among diverse cell
Chemiluminescence assay populations.
The luminol enhanced chemiluminescence of monocytes re- More than 10 years ago, Henderson and coworkers [40]
circulated in presence of Cu, PAN and PS membranes after analyzed neutrophil phagocytosis in a bench circuit in the
stimulation with opsonized Zymosan is shown in Figure 6. presence of cellulose acetate and polysuiphone membranes.
Samples were measured in duplicate at one minute intervals and This function was found to be defective with the former dialyzer
results were expressed as mV light emission. The plotted points when processed cells were mixed with unprocessed serum, but
represent the mean of at least two experiments. They delimit also when processed serum was mixed with unprocessed cells
integrated areas which reflect the results of the phagocytosis of and when both cells and serum had been processed. These
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Fig. 4A. Monocytes recirculated in absence of dialysis membrane. AHGG are evident as granular electrondense material free among the cells and
inside lysosomes in the cytoplasm of a monocyte (arrows) (x 10.200). B. Monocytes recirculated in presence of PS membrane. AHGG show the
same features observed in A. The immunoglobulin nature is proved by immunogold reaction. C. A magnification of the encircled area of B. Gold
granules are recognizable both in granular extracellular material (arrow point) and inside the lysosomes (arrows) (B )< 15.200, C X 38.000). D.
Monocytes recirculated in presence of Cu membrane. AHGG are present around the cells but are never found in the lysosomes (x 11.000).
authors concluded that cellulose acetate had detrimental effects
on the white cell function of phagocytosis.
In order to evaluate single parameters of biotolerance in the
same cell preparation in controlled experimental conditions, we
focused our interest on the most typical function of peripheral
leukocytes and demonstrated that monocytes, recirculated in
presence of cellulose derived membranes, had a remarkable
impairment in Fc receptor phagocytosis. This impairment was
dose dependent in the sense that it increased as exposure time
to the dialyzer increased.
The parallel evaluation of cell viability excluded the possibil-
ity that experimental conditions induced per se gross cellular
changes that could explain this functional impairment.
We supposed that the dialyzer/cell contact could have pro-
duced an internalization of cell surface receptors involved in the
phagocytosis process causing a subsequent frustration of
phagocytosis. If so, we would have expected some receptor
rearrangement after the cell/dialyzer interaction. We were
unable to show, in the experimental conditions applied, any
significant change in surface expression of several receptor
glycoproteins recognized by five monoclonal antibodies.
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Fig. 5. Superoxide anion generation after
stimulation with opsonized Zymosan. In
abscissa: time of exposure to dialysis
membranes. The hatched area represents the
range of values obtained from
non-recirculated control cell preparations. The
histograms are the mean SEM of at least 3
experiments. * P < 0.05 and ** P 0,01 as
compared to the values of control cell
suspensions.
Cycles
FIg. 6. Lumjnol enhanced chemiluminescence of monocytes exposed
to different membranes after Zymosan stimulation. Similar results were










A Apart from a slight increase in AA 3.84 positive cells after
5 recirculation with polysulphone, no significant change was
noted during the in vitro experiments.
10mm The analysis of Fc receptor expression was necessarily
20 mm restricted to the neutrophils due to the unavailability of MoAbs
to monocyte Fc receptors (2nd International Workshop on
Human Leukocyte Differentiation Antigens, Boston, 1984).
Some investigators have shown a decreased number of circu-
lating Fc receptors bearing neutrophils as compared to the same
patients' cells before dialysis was started [41]. In that study,
I I I neutrophil separation to assess Fc receptors number was ob-
1 3 5 7 9 11 13 15 tamed by Ficoll-Hypaque, which is not appropriate for analyz-
Cycles ing leukocyte function after the initiation of dialysis [42], since
cell pellets become unrepresentative of the total leukocyte
population [43].
The AB8.28 MoAb we employed to assess Fc receptor
expression on the same neutrophil suspensions recirculated in
our model, recognizes a structure with Fc function. Indeed it
20 mm was shown to react with a molecule involved in the binding of
aggregated IgG and in the phagocytosis of IgG coated particles
60 mm by human neutrophils [24]. Again, its expression was not
affected by recirculation experiments with any dialysis mem-
brane.
I I I I With respect to the complement receptors, it is worthy
1 3 5 7 9 11 13 15 remembering that a fivefold increase in the mean neutrophil-
Cycles surface expression of Mol, a glycoprotein involved in the
c Cu recognition of particles coated with C3bi, was recently reported
5 to occur within 15 minutes after the start of in vivo dialysis with
Cu membrane [44]. Our finding of unaffected CR1 and CR3
4' expression obtained in vitro in a plama free system is consistent
with the hypothesis proposed by Arnaout and coworkers [44]
that the increase in the expression of the complement receptors
needs the presence of adequate plasma stimuli.
2 In conclusion, the cytofluorimetric analysis of the reactivity
10 mn of all the MoAbs employed did not allow verification of the
' hypothesis of a receptor-dependent phagocytosis impairment.
I I I I I I 60 mm A further possibility explaining this defect could be inferred
1 3 5 7 9 11 13 15 from the observations that cellophane derived membranes
might induce the release of phagocyte cell granular factors [45,
46]. An extracellular release of phagocyte lysosomal hydrolases
could ultimately result in a subsequent defect of phagocytosis
[47, 48]. However, the results of the ultrastructural examination
of the monocytes recirculated with different dialyzer mem-
branes and incubated with heat-aggregated human IgG provided
a marker of monocyte maturation possibly related to alfa evidence for different mechanisms.
interpheron receptors [27] and class II HLA antigen. Both are AHGG were found to be actively phagocytized by unrecir-
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sence of dialyzers and by monocytes exposed to PS, although to
a lesser extent. AHGG were identified in phago-lysosomal
organuli, strictly associated to anti-lgG-bound colloidal gold
particles. In monocyte suspensions recirculated in presence of
Cu dialyzer, AHGG were never found as ingested material.
Nevertheless, AHGG were found to be in contact with cell
plasma membranes, suggesting that, in contrast with phagocy-
tosis process, the receptor-mediated uptake was unaffected.
Considered together, these findings suggested that the defect
was subsequent to the ingestible material/receptor interaction
and preceding the phago-lysosome formation. In other words,
the impaired phagocytosis did not seem due to a receptor
rearrangement nor to a depletion of enzyme content but to an
impaired capacity of receptor-mediated internalization of the
attached material. The defect could possibly involve some
proteins of the cytoskeleton or alternatively some cellular
metabolic pathway.
Our data are not in contrast with the former hypothesis, since
an altered cytoskeleton of processed monocytes could actually
result in an impaired ingestion of particulate immune complexes
and AHGG, paralleled by a maintained capacity of AHGG
uptake [491. On the other hand, since the attachment of immune
complexes to monocytes is a relatively energy-independent
process [50], an acquired deficiency of intracellular energy
sources could explain the combination of effective uptake and
impaired ingestion of AHGG.
The evaluation of energy sources of recirculated monocytes,
as assessed by detecting the cellular potential of oxidizing
species production, provided evidence for the hypothesis of a
metabolic impairment.
Recently, Nguyen and coworkers [17], in co-incubation ex-
periments in vitro, found that the spontaneous chemilumines-
cence emission by neutrophils incubated with Cu in plasma free
conditions was much higher when compared to PAN or in the
absence of dialysis membrane. We could not convincingly
differentiate among the spontaneous chemiluminescence of
monocytes exposed to the diverse membranes since the ob-
tained values were very low. However, by analyzing chemilu-
minescence emission after Zymosan stimulation, we could
establish the residual capacity of oxidizing species generation
after cell/dialyzer interaction and, indirectly, the reciprocal
level of prior cell activation.
While the synthetic membrane of PS did not influence this
activity, Cu-treated cells had a remarkable decrease in oxidiz-
ing species production ability, as if monocytes had undergone a
rapid energy cell exhaustion by contact with this membrane.
Superoxide anion test allowed the detection of significant
defects in monocytes exposed to Cu membranes only after a 30
minute recirculation, when the receptor mediated phagocytosis
of IgG-coated RBC was remarkably reduced as compared to
initial values. This could indicate that the decreased chemilu-
minescence could be due, at least partially, to superoxide-anion
independent mechanisms as suggested in other experimental
conditions [51]. Alternatively, it was conceivable that superox-
ide-ferrycytochrome C reduction test was a less sensitive
measure of cell oxidative potential as compared to the chemi-
luminescence emission assay. Actually, the burst of light results
from the combined oxidizing properties of superoxide, hydro-
gen peroxide, singlet oxygen and hydroxil radical. All these
reactive oxygen species provide oxidizing agents for the oxida-
tion of arachidonic acid that results in chemiluminescence.
Further, chemiluminescence is electronically amplified by the
photomultiplier tube and, chemically, by the addition of lumi-
nol. From these considerations, a major sensitivity of chemilu-
minescence as compared to superoxide anion production test
could reasonably be inferred.
Regardless of the exact mechanism involved, these data on
generation of reactive oxygen species permit the conclusion
that the contact between leukocyte and Cu membrane ulti-
mately results in a defect in cell oxidative potential. This
probably leads to the impaired phagocytosis without affecting
the attachment of immune material. This conclusion also agrees
with the recent suggestion that the circulating phagocytes
exposed to hemodialysis materials incur an exhaustion or
inhibition of post-receptor metabolic events critical to the
intracellular response [52].
In recent years, growing interest has been focused on im-
munoregulatory proteins secreted by monocytes, called cyto-
kines. Among them Interleukin I (ILl) is thought to be the most
important chemical mediator. ILl secretion is associated with a
wide variety of metabolic, immunologic and inflammatory
events [53]. Addition of cellulose membrane particles to plates
containing cultured monocytes enhances monocytes to produce
ILl [54]. PAN membrane was reported to particularly increase
ILl production [55]. This trend is the opposite of the metabolic
profile described here and may suggest that only monocytes
with preserved cell energy sources can adequately respond to
the stimulation of ILl production by the dialysis material.
A distinct trend was noted favoring a greater biocompatibility
of PS membranes, compared not only to Cu, but also to other
commonly used synthetic membranes. This observation agrees
with recent studies showing a reduced impact of PS in compar-
ison to PMME or PAN on some leukocyte functions [56, 57].
Some of the assays we employed, like chemiluminescence,
have been shown to correlate well with the antimicrobial
activity of leukocytes [58]. Therefore, based on our data, a
potentially reduced response to infections in patients on Cu
hemodialysis can be supposed. However, we are aware that the
susceptibility to infections of the hemodialyzed patient is a
multifaceted phenomenon in which, besides the intrinsic risks
of the repeated extracorporeal circulations, a number of both
cellular and plasma factors are involved.
Of interest in the present study, however, is that our model of
simulated dialysis, allowing for the analysis of single parame-
ters of biocompatibility of the dialyzer materials, provides
incontrovertible evidence for non-plasma-mediated unsus-
pected effects of dialysis membranes on peripheral leukocytes.
Interestingly, the combination of impaired receptor-mediated
phagocytosis, normal cell-surface Fc receptor expression and
acquired defect in cell energy sources characterizing Cu-treated
monocyte suspensions, is a particular immunopathological con-
dition which is described in certain autoimmune disorders like
active lupus erythematosus [l8—20, 59].
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